ImmunityBio
IBRX
IBRX
61 hedge funds and large institutions have $39.8M invested in ImmunityBio in 2018 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 23 increasing their positions, 17 reducing their positions, and 8 closing their positions.
Holders
61
Holders Change
-3
Holders Change %
-4.69%
% of All Funds
1.4%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
5
Increased
23
Reduced
17
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
1
Morgan Stanley
New York
|
$385K |
2 |
2
Millennium Management
New York
|
$464K |
3 |
3
Goldman Sachs
New York
|
$133K |
4 |
![]()
4
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$170K |
5 |
5
UBS Group
Zurich,
Switzerland
|
$26K |